$4,841.53 travel Payment -- Gilead Sciences to Dr. Ashley Nelson

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Gilead Sciences made a $4.8K travel payment to Ashley Nelson, a Pulmonology specialist in Lansing, MI. The payment was associated with Wegovy. The payment of $4,841.53 to Dr. Ashley Nelson for travel and lodging related to Wegovy is a significant expense. Gilead Sciences, the payer, is a major pharmaceutical company. The payment was made to a Pulmonology specialist, indicating a focus on respiratory or related conditions.

Patient Guidance: What This Payment Means for You

This payment covered travel and lodging expenses, which may have been for educational purposes related to a medication or medical device. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Travel and lodging payments for specialists can vary widely depending on the nature of the educational event or research. This amount is moderate and should be assessed against typical industry standards for similar events in pulmonology.

Regulatory Context: Sunshine Act Requirements

Payments for travel and lodging must be reported under the Open Payments program if they are made by applicable manufacturers or GPOs to physicians or teaching hospitals.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharma-payments
• physician-payments
• travel-lodging
• gilead-sciences
• wegovy
• pulmonology

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $4.8K payment for?

This was a travel payment of $4.8K from Gilead Sciences to Ashley Nelson, categorized as "Travel and Lodging". It was associated with Wegovy. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Ashley Nelson accept pharmaceutical money?

Yes, Ashley Nelson received this $4.8K payment from Gilead Sciences. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Ashley Nelson's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $4.8K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Pulmonology?

To compare this payment against Pulmonology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Pulmonology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Ashley Nelson's relationship with Gilead Sciences?

The payment covers travel and lodging, suggesting an educational event or conference attendance. This $4.8K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Pulmonology?

Wegovy is a medication primarily used for weight management, which can be relevant to pulmonology patients with comorbidities.

What should patients do after learning about this payment?

This payment covered travel and lodging expenses, which may have been for educational purposes related to a medication or medical device.

What else should I know about this travel payment?

The payment occurred in November 2024, indicating a recent transaction.

Related Reports

• View Dr. Ashley Nelson's full payment report
• Gilead Sciences full spending report
• Browse all Pulmonology payments
• Browse all payments in Michigan
• Search for other payments